Insider Buying Sparks Volatility: Evogene’s Director Recanati Buys 2,500 Shares Amid Negative Sentiment and High Buzz Levels.
Inside Evogene’s latest insider buying, Leon Recanati’s 2,500‑share purchase signals long‑term confidence amid volatile market sentiment and fragile financials.
5 minutes to read